SCHEMBL4852763

SCHEMBL4852763

CCCc1cc(C=CC(=O)c2ccc(OC)cc2F)c(OCCN(C)C)cc1O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
ALOX12 P18054 1/20 0.48
APP P05067 1/20 0.45
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
DPP4 P27487 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853051 0.90 MEN1 (0.44) PTPN1MEN1KMT2ALMNAHPGD
SCHEMBL4852755 0.90 MEN1 (0.44) PTPN1MEN1KMT2ALMNAHPGD
SCHEMBL4855883 0.83 HPGD (0.52) PTPN1MEN1KMT2ALMNAHPGD
SCHEMBL4849956 0.83 LMNA (0.53) MEN1KMT2ALMNAHPGDALDH1A1
SCHEMBL4847397 0.81 LMNA (0.49) PTPN1MEN1KMT2ALMNAHPGD
SCHEMBL4854497 0.80 MEN1 (0.48) MEN1KMT2ALMNAHPGDALDH1A1
SCHEMBL4846635 0.79 LMNA (0.48) PTPN1MEN1KMT2ALMNAHPGD
SCHEMBL4848072 0.78 LMNA (0.48) MEN1KMT2ALMNAHPGDALDH1A1
SCHEMBL4848487 0.77 LMNA (0.46) MEN1KMT2ALMNAHPGDALDH1A1
SCHEMBL4848052 0.77 ABCG2 (0.48) MEN1KMT2ALMNAHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed